Dr. Guang-Yu Yang, MD

Dr. Yang practices at VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia.

Dr. Yang's NPI, 1093798654, was assigned on November 28, 2005. Dr. Yang holds Illinois license 036114404.

Dr. Yang's primary practice is VCU Medical Center, at 1250 East Marshall Street, Richmond, VA 23298 in Richmond City. The practice phone is (804) 828-9000.

Dr. Yang's primary practice is VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia. Dr. Yang is also affiliated with VCU Health Community Memorial Hospital. The medical group on file is MCV Physicians. Dmand AI also links Dr. Yang to 1 more urgent care center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yang practices, 3 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Yang's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dmand AI has Dr. Yang's licenses on file in 2 states: Illinois and Virginia.

CMS data shows 1,264 Medicare services from Dr. Yang across 9 procedure codes in 2024, for 461 Medicare patients. Medicare paid $36,034 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 461 Medicare patients who saw Dr. Yang in 2024. The largest group is 65 to 74, with 242 patients. 74% of them have high cholesterol, and 70% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yang's median patient age at 59, with 48% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Yang for performance year 2024, reported through an alternative payment model (APM). Dr. Yang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Yang from 3 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 66% of the total. Abbvie Inc. paid the most, $625. It also lists 1 research payment totaling $323 in 2025.